Gene · 2887
Papers1,547
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 1,547
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| DNA Methylation and Recurrent Pregnancy Loss: A Mysterious Compass? | Front Immunol | 2021 | 34745108 | PubTator, text mining | PubMed |
| Gene-level analysis of rare variants in 379,066 whole exome sequences identifies an association of GIGYF1 loss of function with type 2 diabetes. | Sci Rep | 2021 | 34732801 | PubTator, text mining | PubMed |
| The prevalence of DNA microsatellite instability in anaplastic thyroid carcinoma - systematic review and discussion of current therapeutic options. | Contemp Oncol (Pozn) | 2021 | 34729042 | PubTator, text mining | PubMed |
| Interactions Among lncRNA/circRNA, miRNA, and mRNA in Musculoskeletal Degenerative Diseases. | Front Cell Dev Biol | 2021 | 34708047 | PubTator, text mining | PubMed |
| Strengthening the reporting of observational studies in epidemiology using mendelian randomisation (STROBE-MR): explanation and elaboration. | BMJ | 2021 | 34702754 | PubTator, text mining | PubMed |
| Extracellular Vesicles in Acute Leukemia: A Mesmerizing Journey With a Focus on Transferred microRNAs. | Front Cell Dev Biol | 2021 | 34692712 | PubTator, text mining | PubMed |
| Signaling Pathways That Regulate Normal and Aberrant Red Blood Cell Development. | Genes (Basel) | 2021 | 34681039 | PubTator, text mining | PubMed |
| Expression Profiles and Prognostic Value of FABPs in Colorectal Adenocarcinomas. | Biomedicines | 2021 | 34680577 | PubTator, text mining | PubMed |
| Playing the Devil's Advocate: Should We Give a Second Chance to mTOR Inhibition in Renal Clear Cell Carcinoma? - ie Strategies to Revert Resistance to mTOR Inhibitors. | Cancer Manag Res | 2021 | 34675658 | PubTator, text mining | PubMed |
| mTORC1 promotes malignant large cell/anaplastic histology and is a targetable vulnerability in SHH-TP53 mutant medulloblastoma. | JCI Insight | 2021 | 34673573 | PubTator, text mining | PubMed |
| Translational repression of NMD targets by GIGYF2 and EIF4E2. | PLoS Genet | 2021 | 34665823 | PubTator, text mining | PubMed |
| Left Ventricular Hypertrophy in Diabetic Cardiomyopathy: A Target for Intervention. | Front Cardiovasc Med | 2021 | 34660744 | PubTator, text mining | PubMed |
| miR-338-5p-ZEB2 axis in Diagnostic, Therapeutic Predictive and Prognostic Value of Gastric Cancer. | J Cancer | 2021 | 34659565 | PubTator, text mining | PubMed |
| Insulin Resistance, Secretion and Clearance -Taming the Three Effector Encounter of Type 2 Diabetes. | Front Endocrinol (Lausanne) | 2021 | 34659123 | PubTator, text mining | PubMed |
| GRB10 rs1800504 Polymorphism Is Associated With the Risk of Coronary Heart Disease in Patients With Type 2 Diabetes Mellitus. | Front Cardiovasc Med | 2021 | 34651026 | PubTator, text mining | PubMed |
| TTPAL promotes gastric tumorigenesis by directly targeting NNMT to activate PI3K/AKT signaling. | Oncogene | 2021 | 34642500 | PubTator, text mining | PubMed |
| Genotype-Phenotype Correlations in Monogenic Parkinson Disease: A Review on Clinical and Molecular Findings. | Front Neurol | 2021 | 34630269 | PubTator, text mining | PubMed |
| Targeting the Integrated Stress Response in Cancer Therapy. | Front Pharmacol | 2021 | 34630117 | PubTator, text mining | PubMed |
| Heart failure in diabetes. | Metabolism | 2021 | 34627874 | PubTator, text mining | PubMed |
| Double paternal uniparental isodisomy 7 and 15 presenting with Beckwith-Wiedemann spectrum features. | Cold Spring Harb Mol Case Stud | 2021 | 34615670 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2887/papers?page=17